• 1
    American Cancer Society. Cancer facts and figures 2004. Atlanta: American Cancer Society, 2004.
  • 2
    Kim JH, Sarani B, Orkin BA, et al. HIV-positive patients with anal cancer have poorer treatment tolerance and outcome than HIV-negative patients. Dis Colon Rectum. 2001; 44: 14961502.
  • 3
    Gamagami RA, Chiotasso P, Lazorthes F. Continent perineal colostomy after abdominoperineal resection: outcome after 63 cases. Dis Colon Rectum. 1999; 42: 626630; discussion, 630–631.
  • 4
    Melbye M, Rabkin C, Frisch M, Biggar RJ. Changing patterns of anal cancer incidence in the United States, 1940-1989. Am J Epidemiol. 1994; 139: 772780.
  • 5
    Palefsky JM, Holly EA, Gonzales J, Berline J, Ahn DK, Greenspan JS. Detection of human papillomavirus DNA in anal intraepithelial neoplasia and anal cancer. Cancer Res. 1991; 51: 10141019.
  • 6
    Bjorge T, Engeland A, Luostarinen T, et al. Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. Br J Cancer. 2002; 87: 6164.
  • 7
    Durante AJ, Williams AB, Da Costa M, Darragh TM, Khoshnood K, Palefsky JM. Incidence of anal cytological abnormalities in a cohort of human immunodeficiency virus-infected women. Cancer Epidemiol Biomarkers Prev. 2003; 12: 638642.
  • 8
    Ogunbiyi OA, Scholefield JH, Robertson G, Smith JH, Sharp F, Rogers K. Anal human papillomavirus infection and squamous neoplasia in patients with invasive vulvar cancer. Obstet Gynecol. 1994; 83: 212216.
  • 9
    Holly EA, Ralston ML, Darragh TM, Greenblatt RM, Jay N, Palefsky JM. Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst. 2001; 93: 843849.
  • 10
    Daling JR, Weiss NS, Hislop TG, et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med. 1987; 317: 973977.
  • 11
    Frisch M, Glimelius B, van den Brule AJ,et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med. 1997; 337: 13501358.
  • 12
    Holmes F, Borek D, Owen-Kummer M, et al. Anal cancer in women. Gastroenterology. 1988; 95: 107111.
  • 13
    Daling JR, Sherman KJ, Hislop TG, et al. Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol. 1992; 135: 180189.
  • 14
    Frisch M, Glimelius B, Wohlfahrt J, Adami HO, Melbye M. Tobacco smoking as a risk factor in anal cancer: an antiestrogenic mechanism? J Natl Cancer Inst. 1999; 91: 708715.
  • 15
    Frisch M, Smith E, Grulich A, Johansen C. Cancer in a population-based cohort of men and women in registered homosexual partnerships. Am J Epidemiol. 2003; 157: 966972.
  • 16
    Palefsky JM, Holly EA, Ralston ML, Jay N, Berry JM, Darragh TM. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS. 1998; 12: 495503.
  • 17
    Grulich AE, Li Y, McDonald A, Correll PK, Law MG, Kaldor JM. Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS. 2002; 16: 11551161.
  • 18
    Daling JR, Madeleine, MM, Johnson LG, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer. 2004; 101: XXXXXX.
  • 19
    National Cancer Institute. Requirements of CoC/governing agencies [monograph online]. Available from URL: [accessed Sept. 2003].
  • 20
    National Cancer Institute Division of Cancer Control and Population Sciences. Surveillance, Epidemiology, and End Results (SEER) Program public-use data (1973–1999). Washington, DC: National Cancer Institute, 2002.
  • 21
    Young JL Jr., Roffers SD, Ries LA, Fritz AG, Hurlbut AA, editors. SEER summary staging manual—2000: breast and female genital system [monograph online]. Available from URL:
  • 22
    Kleinbaum DG, Kupper LL, Muller KE, Nizam A. Applied regression analysis and other multivariable methods (3rd edition). Pacific Grove, CA: Duxbury Press, 1998.
  • 23
    Rosner B. Fundamentals of biostatistics (4th edition). Belmont, CA: Wadsworth, 1995.
  • 24
    National Cancer Institute. NCI fact sheet: how changes in U.S. Census counts affect NCI cancer rates [monograph online]. Available from URL: [accessed Sept. 2003].
  • 25
    Sturgeon S, Brinton L, Devesa S, Kurman RJ. In situ and invasive vulvar cancer incidence trends (1973 to 1987). Am J Obstet Gynecol. 1992; 166: 14821485.
  • 26
    Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Palefsky JM. Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men. Am J Med. 2000; 108: 634641.
  • 27
    Palefsky JM, Holly EA, Hogeboom CJ, Berry JM, Jay N, Darragh TM. Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr Hum Retrovirol. 1997; 14: 415422.
  • 28
    Tilston P. Anal human papillomavirus and anal cancer. J Clin Pathol. 1997; 50: 625634.
  • 29
    Anderson JE, Stall R. Increased reporting of male-to-male sexual activity in a national survey. Sex Transm Dis. 2002; 29: 643646.
  • 30
    National Center for Health Statistics. Current smoking by persons 18 years of age and over according to sex, race, and age: United States, selected years 1965–99 [monograph online]. Available from URL: [accessed Sept. 2003].
  • 31
    Critchlow CW, Surawicz CM, Holmes KK, et al. Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: influence of HIV infection, immunosuppression and human papillomavirus infection. AIDS. 1995; 9: 12551262.
  • 32
    Palefsky JM, Holly EA, Ralston ML, et al. Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: prevalence and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 17: 320326.
  • 33
    National Center for HIV, STD and TB Prevention. Basic statistics [monograph online]. Available from URL: [accessed Sept. 2003].
  • 34
    Department of Health and Human Services, Public Health Service. HIV/AIDS surveillance report. Volume 13. Atlanta: Centers for Disease Control and Prevention, 2001.
  • 35
    McNaghten AD, Hanson DL, Dworkin MS, Jones JL. Differences in prescription of antiretroviral therapy in a large cohort of HIV-infected patients. J Acquir Immune Defic Syndr. 2003; 32: 499505.
  • 36
    Whiteford MH, Stevens KR Jr., Oh S, Deveney KE. The evolving treatment of anal cancer: how are we doing? Arch Surg. 2001; 136: 886891.
  • 37
    Proctor BD, Dalaker J. U.S. Census Bureau current population reports: poverty in the United States, 2002. Washington, DC: U.S. Government Printing Office, 2003.
  • 38
    Farley JH, Hines JF, Taylor RR, et al. Equal care ensures equal survival for African-American women with cervical cancer. Cancer. 2001; 91: 869873.
  • 39
    Hughes JP, Garnett GP, Koutsky L. The theoretical population-level impact of a prophylactic human papilloma virus vaccine. Epidemiology. 2002; 13: 631639.